Epsilon Healthcare Limited Stock Other OTC
Equities
HDRPF
AU0000137598
Pharmaceuticals
Sales 2021 | 5.5M 3.63M | Sales 2022 | 7.11M 4.7M | Capitalization | 7.51M 4.96M |
---|---|---|---|---|---|
Net income 2021 | -9M -5.95M | Net income 2022 | -13M -8.59M | EV / Sales 2021 | 3.26 x |
Net Debt 2021 | 2.1M 1.39M | Net Debt 2022 | 2.34M 1.54M | EV / Sales 2022 | 1.38 x |
P/E ratio 2021 |
-1.48
x | P/E ratio 2022 |
-0.38
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 60.39% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Sanghera
CEO | Chief Executive Officer | - | Nov. 20 |
Lin Li
AUD | Comptroller/Controller/Auditor | - | - |
Marcelo Mora
SEC | Corporate Secretary | 60 | 22-12-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Beasley
CHM | Chairman | - | 16-08-28 |
Stuart Cameron
BRD | Director/Board Member | - | 22-10-26 |
Xiao Cui
CHM | Chairman | - | 22-10-27 |
1st Jan change | Capi. | |
---|---|---|
+29.98% | 684B | |
+30.34% | 568B | |
-3.52% | 361B | |
+18.59% | 329B | |
+4.07% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.09% | 166B |